Smar NetworkSmar.inSmargrid.comNewsInsuranceRoomsGamesMeasurements

Insurance Daily News

Daily news and analysis on insurance industry trends, regulations, and market insights

Facebook Telegram
← Back to Insurance News

Humana rebounds star ratings, eyes $4.8bn bonus

📅 2026-11-09 | 📰 Insurance Business America
#humana #medicare advantage #star ratings #broker commissions #bonus payments

Humana reported third-quarter revenue of $41.2 billion, up from $32.6 billion a year earlier, and an insurance segment benefit ratio of 93.7 percent, beating its own guidance of just above 94 percent. The company also raised its full-year adjusted earnings per share outlook to at least $9.50 from at least $9.00.

The strong top line follows a two-year reset that began when only twenty percent of Humana’s Medicare Advantage members were enrolled in four-star or higher plans—a drop from ninety-four percent in early 2024. Management estimated that the rating collapse would create a $3.5 billion net revenue headwind, prompting a series of actions that reached deep into the broker channel.

CenterWell, Humana’s health services arm, added nearly 147,000 primary-care patients year-to-date, a thirty-percent increase, and generated $7.2 billion in revenue, up from $5.9 billion in the comparable prior quarter. The carrier also announced a joint venture with HPS, now part of BlackRock after a 2025 acquisition, replacing earlier partnerships with Welsh, Carson, Anderson & Stowe. The new structure lowers Humana’s cost of capital and removes a put option that would have required funding in 2027, freeing balance-sheet capacity ahead of expected star-bonus payments.

Humana’s individual Medicare Advantage enrollment grew roughly twenty-five percent over 2025, adding about one million members during the annual enrollment period alone. New members tend to have higher benefit ratios, contributing to a year-over-year benefit-ratio increase of 260 basis points from 91.1 percent. The surge in enrollment widened the gap between premium revenue and medical costs, especially as older, higher-acuity beneficiaries used care more frequently than modeled.

In October 2026, CMS released its 2027 star ratings, and Humana’s standing shifted dramatically. Ninety-five percent of Humana’s members are now in plans rated four stars or higher for 2027, compared with just twenty percent a year earlier. Star ratings determine eligibility for quality bonus payments, which reached $13.4 billion across the Medicare Advantage market in 2026, according to a KFF analysis. Evercore ISI analysts estimate the improved ratings could generate approximately $4.8 billion in government bonus payments for Humana in 2028, though the ultimate earnings impact will depend on how much of that funding Humana reinvests in member benefits and provider arrangements.

CEO Jim Rechtin said the company is “increasingly driving financial and operating performance toward being ‘ahead’ of our plan.” During the Q3 earnings call, he noted that early enrollment activity in the annual enrollment period, which runs through December 7, is ahead of expectations and that membership is expected to rise for 2027. CFO Celeste Mellet credited “really strong relationships with our broker partners” and consolidation among smaller plans for part of the outperformance.

The star-rating collapse also triggered a reduction in broker commissions. Humana stopped paying commissions on roughly one-third of its products, according to a TD Cowen note. A November 2026 Health Affairs study found that the removal of broker commissions across the Medicare Advantage market led to a twenty-one percent decline in enrollment in affected plans between mid-2025 and January 2026, highlighting the influence of advisor behavior on beneficiary choices. CMS set the 2027 fair market value for initial Medicare Advantage commissions at $725 per member per year in most states, with renewals at $363. Humana has not publicly committed to restoring commissions on the products where they were removed, leaving open the question of whether the carrier will continue to steer enrollment through direct channels or revert to traditional broker compensation.

The outcome will affect which Humana products advisors can viably recommend to clients heading into the 2027 plan year, as commission structures shape product profitability and market access.

Why it matters

Broker commissions and star-rating recovery directly impact the profitability and product mix that insurance advisors can offer their Medicare Advantage clients.

FAQ

What was Humana’s third-quarter revenue?
Humana posted $41.2 billion in revenue for the quarter ended September 30.

How much could the star-rating improvement be worth in bonuses?
Analysts estimate the improved ratings could generate about $4.8 billion in government bonus payments for Humana in 2028.

What proportion of Humana’s members are now in four-star or higher plans?
Ninety-five percent of Humana’s members are now in plans rated four stars or higher for 2027.

What change did Humana make to broker commissions?
Humana stopped paying commissions on roughly one-third of its products.

Source: Insurance Business America. See the original source for full details.